Related Experiment Video
Updated: Jan 8, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Non-pharmacological approaches in gastroesophageal reflux disease: Evidence-based dietary and lifestyle interventions
Luisa Bertin1, Federico Caldart2, Edoardo Vincenzo Savarino1
1Department of Surgery, Oncology and Gastroenterology, University of Padova, 35128, Padova, Italy; Gastroenterology Unit, Azienda Ospedale Università di Padova, 35128, Padova, Italy.
Abstract:
Gastroesophageal reflux disease (GERD) affects 18-28 % of Western populations, with 10-40 % experiencing refractory symptoms despite proton pump inhibitor therapy. We conducted a comprehensive narrative review of dietary interventions in GERD, analyzing studies that measured clinical efficacy through validated symptom scores (GERD-Q, RDQ) and objective reflux parameters (24-h pH-impedance monitoring, acid exposure time). We examined pathophysiological mechanisms, intervention efficacy, and clinical implementation strategies across diverse patient populations. Structured dietary interventions demonstrate clinically meaningful outcomes with robust mechanistic rationale. Low-carbohydrate approaches achieved significant reductions in esophageal acid exposure time (mean difference -2.83 %, 95 % CI: -4.554 to -1.114, p < 0.001), while systematic trigger food elimination protocols achieved 23 % improvement in GERD-Q scores, enabling 45 % of patients to discontinue pharmacological therapy. Plant-based dietary patterns showed remarkable protective effects with 50 % reduction in GERD prevalence (OR = 1.96, 95 % CI 1.22-3.17 for animal food consumption). Weight management interventions demonstrated exceptional efficacy in overweight patients, with GERD prevalence decreasing from 37 % to 15 % (p < 0.01) and 65 % achieving complete symptom resolution. Individual dietary trigger identification achieved high success rates with standardized protocols. Evidence-based dietary interventions offer clinically meaningful alternatives or adjuncts to pharmacological therapy. However, significant study heterogeneity and predominance of short-term trials limit definitive clinical recommendations. Future research should prioritize developing validated precision medicine algorithms integrating clinical phenotyping, genetic markers, and microbiome profiling to optimize personalized dietary prescriptions and investigate long-term sustainability of dietary modifications.
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

